Literature DB >> 2853072

Phencyclidine blocks histamine H3-receptors in rat brain.

J M Arrang1, N Defontaine, J C Schwartz.   

Abstract

Phencyclidine (PCP) was examined for its ability to modulate histamine release from rat brain slices labeled with L-[3H]histidine. PCP failed to mimic but completely reversed the autoinhibitory effect of histamine at H3-receptors with an apparent Ki value of 13 +/- 3 microM. A direct interaction of PCP with H3-autoreceptors rather than PCP or sigma receptor sites was confirmed by binding studies. PCP inhibited the binding of [3H](R)alpha-methylhistamine to H3-receptor sites in rat cerebral membranes with a Ki value of 25 +/- 2 microM. It is concluded that PCP is a H3-receptor antagonist of moderate potency.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853072     DOI: 10.1016/0014-2999(88)90467-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard
Journal:  Agents Actions       Date:  1990-04

Review 2.  An update on histamine H3 receptors and gastrointestinal functions.

Authors:  G Bertaccini; G Coruzzi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 3.  Histamine-4 Receptor: Emerging Target for the Treatment of Neurological Diseases.

Authors:  Ling Shan; Gerard J M Martens; Dick F Swaab
Journal:  Curr Top Behav Neurosci       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.